Abstract
Toxicity associated with long-term bevacizumab use in patients with recurrent ovarian cancer: A multi-institutional study
Full Text
Sign-in/Register to access full text options
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have